Search for a column or news alert.
Subscribe to KIAH Feed
Register for our free eNewsletter and receive important updates on health conditions as well as diet and lifestyle information.
Sign-up to receive eNewsletter
KIAH Blog

Unauthorized Smoking Cessation Product Resolve May Pose Health Risk

Posted on July 31, 2007 by Claire Sowerbutt.

Advisory

2007-92
July 27, 2007
For immediate release

Unauthorized Smoking Cessation Product Resolve May Pose Health Risk

OTTAWA - Health Canada is advising Canadians not to use the unauthorized smoking cessation product Resolve, because of the potential health risk to consumers.  

The product contains an unacceptable amount of an ingredient labeled as "CESTEMENOL-350." Consuming excessive amounts of this ingredient might result in damage to the kidney, liver or red blood cells.

Resolve is advertised as a natural stop smoking aid and is available in Cool Peppermint and Wild Cherry flavors. Resolve is distributed by The Winning Combination Inc. These products have been sold in retail stores across the country and are also available over the Internet.

Resolve is not authorized for sale in Canada and Health Canada has asked the company to recall the products. To date, the company has not complied with Health Canada’s request. Health Canada will take further action to remove the product from the market.

Health Canada advises retailers to remove the product from their shelves. Consumers should return the product to the place of purchase.

Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Drug Identification Number for Homeopathic Medicine (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

Consumers requiring more information about this advisory can contact Health Canada’s public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.

To report a suspected adverse reaction to this product, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods:
Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789

CADRMP
Marketed Health Products Directorate
Ottawa, ON, AL 0701C
K1A 0K9
email: cadrmp@hc-sc.gc.ca

The CADRMP adverse reaction reporting form, including a version that can be completed and submitted online, is located on the MedEffect area of the Health Canada Web site.

TERMS OF USE | PRIVACY POLICY | SITE MAP | CONTACT US |
KIAH HOME | KIAH EBOOKS | HEALTH DIRECTORIES | KIAH COLUMNS AND ARCHIVES | KIAH HEALTH LIBRARY | KIAH BLOG | ABOUT KIAH

Copyright © 2008 CS Communication Ltd | info@knowitallhealth.com
PO Box# 14323, Granville Island PO, Vancouver, British Columbia, Canada, V6H 5C5